Insider · CIK 0001218483

GORDON KEVIN K

Reports to the SEC for 5 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001218483

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-10	PGNYProgyny, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	22,000
2026-09-10	PGNYProgyny, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	22,000
2026-09-10	PGNYProgyny, Inc.S Sale	Director	SSale	−11.5K sh	$27.94	−$321K	6,792
2026-09-10	PGNYProgyny, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22K sh	$13.00	+$286K	28,792
2026-09-10	PGNYProgyny, Inc.S Sale	Director	SSale	−11.5K sh	$27.12	−$312K	6,792
2026-09-10	PGNYProgyny, Inc.F Tax Payment	Director	FTax Payment	−10.5K sh	$27.24	−$286K	18,292
2026-09-10	PGNYProgyny, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22K sh	$13.00	+$286K	28,792
2026-09-10	PGNYProgyny, Inc.F Tax Payment	Director	FTax Payment	−10.5K sh	$27.24	−$286K	18,292
2026-05-27	PGNYProgyny, Inc.J Other	Director	JOther	−2,526 sh	—	—	6,792
2026-05-27	PGNYProgyny, Inc.S Sale	Director	SSale	−5,500 sh	$24.99	−$137K	9,318
2026-05-27	PGNYProgyny, Inc.J Other	Director	JOther	+2,526 sh	—	—	15,027
2026-05-21	PGNYProgyny, Inc.A Award	Director	AAward	+6,792 sh	—	—	14,818
2026-05-21	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30.4K sh	—	—	30,373
2025-08-11	PGNYProgyny, Inc.S Sale	Director	SSale	−2,500 sh	$22.04	−$55.1K	12,501
2025-05-22	PGNYProgyny, Inc.A Award	Director	AAward	+8,026 sh	—	—	13,173
2025-05-22	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,049
2025-05-22	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,600 sh	—	—	6,600
2024-05-23	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.2K sh	—	—	23,212
2024-05-23	PGNYProgyny, Inc.A Award	Director	AAward	+5,147 sh	—	—	8,801
2023-12-11	PGNYProgyny, Inc.S Sale	Director	SSale	−2,500 sh	$35.93	−$89.8K	9,854
2023-05-24	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,990
2023-05-24	PGNYProgyny, Inc.S Sale	Director	SSale	−1,410 sh	$38.24	−$53.9K	12,354
2023-05-24	PGNYProgyny, Inc.A Award	Director	AAward	+3,654 sh	—	—	13,764
2022-10-24	PGNYProgyny, Inc.A Award	Director	AAward	+2,900 sh	—	—	10,110
2022-10-24	PGNYProgyny, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2022-06-08	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2022-06-08	VCYTVERACYTE, INC.S Sale	Director	SSale	−15K sh	$18.50	−$278K	8,720
2022-06-08	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$7.39	+$111K	23,720
2021-10-24	PGNYProgyny, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14.7K sh	—	—	14,658
2021-10-24	PGNYProgyny, Inc.A Award	Director	AAward	+2,210 sh	—	—	7,210
2021-06-08	VCYTVERACYTE, INC.A Award	Director	AAward	+8,720 sh	—	—	8,720
2021-01-04	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	15,000
2021-01-04	VCYTVERACYTE, INC.S Sale	Director	SSale	−5,523 sh	$49.27	−$272K	0
2021-01-04	VCYTVERACYTE, INC.S Sale	Director	SSale	−4,477 sh	$48.62	−$218K	5,523
2021-01-04	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.39	+$73.9K	10,000
2020-11-12	VCYTVERACYTE, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.39	+$73.9K	10,000
2020-11-12	VCYTVERACYTE, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	25,000
2020-11-12	VCYTVERACYTE, INC.S Sale	Director	SSale	−1,806 sh	$47.85	−$86.4K	0
2020-11-12	VCYTVERACYTE, INC.S Sale	Director	SSale	−8,194 sh	$46.95	−$385K	1,806
2020-10-24	PGNYProgyny, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2020-10-24	PGNYProgyny, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-06-08	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-10-24	PGNYProgyny, Inc. · Stock Option (right to buy)A Award	Director	AAward	+44K sh	—	—	44,000
2019-06-12	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-02-22	Liquidia Technologies IncS Sale	President and CFO	SSale	−438 sh	$18.09	−$7,923.42	162,265
2019-02-22	Liquidia Technologies IncS Sale	President and CFO	SSale	−212 sh	$16.83	−$3,567.96	162,703
2019-02-22	Liquidia Technologies IncS Sale	President and CFO	SSale	−293 sh	$15.83	−$4,638.19	162,915
2019-01-22	Liquidia Technologies IncS Sale	President and CFO	SSale	−8,355 sh	$14.84	−$124K	163,208
2019-01-22	Liquidia Technologies IncS Sale	President and CFO	SSale	−2,967 sh	$14.14	−$42K	171,563
2018-10-12	Liquidia Technologies IncA Award	President and CFO	AAward	+5,870 sh	—	—	174,530

Recent filings

Accepted (ET)
Sep 184/A
GORDON KEVIN K0001551306-26-000154
SEC(opens sec.gov)
Sep 144
GORDON KEVIN K0001551306-26-000152
SEC(opens sec.gov)
May 294
GORDON KEVIN K0001551306-26-000112
SEC(opens sec.gov)
May 264
GORDON KEVIN K0001551306-26-000103
SEC(opens sec.gov)
Aug 134
GORDON KEVIN K0001551306-25-000169
SEC(opens sec.gov)
May 274
GORDON KEVIN K0001551306-25-000122
SEC(opens sec.gov)
May 284
GORDON KEVIN K0001551306-24-000124
SEC(opens sec.gov)
Dec 134
GORDON KEVIN K0001551306-23-000112
SEC(opens sec.gov)

Companies

Address

C/O PROGYNY, INC. 1359 BROADWAY, 2ND FLOOR

NEW YORK, NY, 10018